Biography
Lukas Bolini is currently a Post-Doctoral associate with the Galluzzi Lab, where he investigates the role of γδ T cells and mast cells in the development and treatment sensitivity of HR+ breast cancer. Prior to joining the Galluzzi Lab (2025), he was a Ph.D. student with the Inflammation Lab in the Biophysics Institute Carlos Chagas Filho at the Federal University of Rio de Janeiro (Brazil; 2019-2024), where he obtained his Ph.D. in Physiology (2024) after obtaining his B.Sc. (2017) in Microbiology and Immunology and his M.Sc. (2019) in Physiology from the Federal University of Rio de Janeiro (Brazil). Lukas has a long-standing interest in the role of rare leukocytes in the pathophysiology of inflammatory diseases and cancer.
(Co)-first Authored Publications
- Bolini, L., Naulin, F., Johnson, N. and L. Galluzzi. Germline BRCA2 mutations foster resistance to CDK4/6 inhibitors in breast cancer. NPJ Precis Oncol, 2026. 10(1): p. 180
- Bolini, L., Habib J.G. and L. Galluzzi. Cytokine signaling and resistance to CDK4/6 inhibitors in HR+HER2- breast cancer. NPJ Precis Oncol, 2025. 9(1): p. 325.
- Bolini, L., Knott, S.R.V. and L. Galluzzi. A macrophage-neutrophil program drives mammary carcinogenesis. Trends Cancer, 2025. 11(5): p. 427-429.
(Co)-senior Authored Publications
- Almeida, H., Ghazal, A.M, Brackett S., et al. Interrogating sequencing data for transcriptional signatures of mitochondrial abundance. Methods Cell Biol, 2027. IN PRESS.
Fellowships
- Fox Chase Cancer Center (FCCC) 2025/2027 Post-doctoral Kirby Fellowship
My Bibliography Link
https://www.ncbi.nlm.nih.gov/myncbi/lukas.bolini.1/bibliography/public/